AIM: To determine if primary murine colonic epithelial cells (CEC) respond to commensal bacteria and discriminate between different types of bacteria. METHODS: A novel CEC: bacteria co-culture system was used to compare the ability of the colonic commensal bacteria, Bacteroides ovatus, E. coli (SLF) and Lactobacillus rhamnosus (LGG) to modulate production of different cytokines (n = 15) by primary CEC. Antibody staining and flow cytometry were used to investigate Toll-like receptor (TLR) expression by CEC directly ex vivo and TLR responsiveness was determined by examining the ability of TLR ligands to influence CEC cytokine production. RESULTS: Primary CEC constitutively expressed functional TLR2 and TLR4. Cultured in complete medium alone, CEC secreted IL-6, MCP-1 and IP-10 the levels of which were significantly increased upon addition of the TLR ligands peptidoglycan (PGN) and lipopolysaccharide (LPS). Exposure to the commensal bacteria induced or up-regulated different patterns of cytokine production and secretion. E. coli induced production of MIP-1alpha/beta and betadefensin3 whereas B. ovatus and L. rhamnosus exclusively induced MCP-1 and MIP-2alpha expression, respectively. TNFalpha, RANTES and MEC were induced or up-regulated in response to some but not all of the bacteria whereas ENA78 and IP-10 were up-regulated in response to all bacteria. Evidence of bacterial interference and suppression of cytokine production was obtained from mixed bacterial: CEC co-cultures. Probiotic LGG suppressed E. coli- and B. ovatus-induced cytokine mRNA accumulation and protein secretion. CONCLUSION: These observations demonstrate the ability of primary CEC to respond to and discriminate between different strains of commensal bacteria and identify a mechanism by which probiotic bacteria (LGG) may exert anti-inflammatory effects in vivo.
AIM: To determine if primary murine colonic epithelial cells (CEC) respond to commensal bacteria and discriminate between different types of bacteria. METHODS: A novel CEC: bacteria co-culture system was used to compare the ability of the colonic commensal bacteria, Bacteroides ovatus, E. coli (SLF) and Lactobacillus rhamnosus (LGG) to modulate production of different cytokines (n = 15) by primary CEC. Antibody staining and flow cytometry were used to investigate Toll-like receptor (TLR) expression by CEC directly ex vivo and TLR responsiveness was determined by examining the ability of TLR ligands to influence CEC cytokine production. RESULTS: Primary CEC constitutively expressed functional TLR2 and TLR4. Cultured in complete medium alone, CEC secreted IL-6, MCP-1 and IP-10 the levels of which were significantly increased upon addition of the TLR ligands peptidoglycan (PGN) and lipopolysaccharide (LPS). Exposure to the commensal bacteria induced or up-regulated different patterns of cytokine production and secretion. E. coli induced production of MIP-1alpha/beta and betadefensin3 whereas B. ovatus and L. rhamnosus exclusively induced MCP-1 and MIP-2alpha expression, respectively. TNFalpha, RANTES and MEC were induced or up-regulated in response to some but not all of the bacteria whereas ENA78 and IP-10 were up-regulated in response to all bacteria. Evidence of bacterial interference and suppression of cytokine production was obtained from mixed bacterial: CEC co-cultures. Probiotic LGG suppressed E. coli- and B. ovatus-induced cytokine mRNA accumulation and protein secretion. CONCLUSION: These observations demonstrate the ability of primary CEC to respond to and discriminate between different strains of commensal bacteria and identify a mechanism by which probiotic bacteria (LGG) may exert anti-inflammatory effects in vivo.
Authors: N Borruel; M Carol; F Casellas; M Antolín; F de Lara; E Espín; J Naval; F Guarner; J R Malagelada Journal: Gut Date: 2002-11 Impact factor: 23.059
Authors: M S Inan; V Tolmacheva; Q S Wang; D W Rosenberg; C Giardina Journal: Am J Physiol Gastrointest Liver Physiol Date: 2000-12 Impact factor: 4.052
Authors: Gil Melmed; Lisa S Thomas; Nahee Lee; Samuel Y Tesfay; Katie Lukasek; Kathrin S Michelsen; Yuehua Zhou; Bing Hu; Moshe Arditi; Maria T Abreu Journal: J Immunol Date: 2003-02-01 Impact factor: 5.422
Authors: Sheena M Cruickshank; Nicholas R English; Peter J Felsburg; Simon R Carding Journal: World J Gastroenterol Date: 2005-10-28 Impact factor: 5.742
Authors: Wendy S Garrett; Graham M Lord; Shivesh Punit; Geanncarlo Lugo-Villarino; Sarkis K Mazmanian; Susumu Ito; Jonathan N Glickman; Laurie H Glimcher Journal: Cell Date: 2007-10-05 Impact factor: 41.582
Authors: Rowann Bowcutt; Ruth Forman; Maria Glymenaki; Simon Richard Carding; Kathryn Jane Else; Sheena Margaret Cruickshank Journal: World J Gastroenterol Date: 2014-11-07 Impact factor: 5.742
Authors: Sheena M Cruickshank; Matthew L Deschoolmeester; Marcus Svensson; Gareth Howell; Aikaterini Bazakou; Larisa Logunova; Matthew C Little; Nicholas English; Matthias Mack; Richard K Grencis; Kathryn J Else; Simon R Carding Journal: J Immunol Date: 2009-03-01 Impact factor: 5.422
Authors: Mohamed Hafez; Kelly Hayes; Marie Goldrick; Geoff Warhurst; Richard Grencis; Ian S Roberts Journal: Infect Immun Date: 2009-04-20 Impact factor: 3.441
Authors: Louise H Zeuthen; Lisbeth N Fink; Stine B Metzdorff; Matilde B Kristensen; Tine R Licht; Christine Nellemann; Hanne Frøkiaer Journal: BMC Immunol Date: 2010-01-19 Impact factor: 3.615